Effect of tacrolimus (FK506) in dystrophic epidermolysis bullosa: rationale and preliminary results
Arch Dermatol
.
1994 Nov;130(11):1457-8.
doi: 10.1001/archderm.130.11.1457.
Authors
P B Carroll
,
H L Rilo
,
K Abu Elmagd
,
N Johnson
,
C Carter
,
H Wright
,
B Jegasothy
,
T E Starzl
,
D H Van Thiel
PMID:
7526802
DOI:
10.1001/archderm.130.11.1457
No abstract available
Publication types
Case Reports
Letter
MeSH terms
Child, Preschool
Epidermolysis Bullosa Dystrophica / drug therapy*
Epidermolysis Bullosa Dystrophica / pathology
Humans
Male
Tacrolimus / therapeutic use*
Substances
Tacrolimus